SPRO vs SRRK Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — SPRO scores higher on quality with 7.5/10 vs SRRK's 5.1/10. SPRO trades at $2.83 while SRRK trades at $44.68. Both analyzed daily using SEC EDGAR data across 13 institutional models.

SPRO

Biotechnology

Spero Therapeutics, Inc.

Quality

7.5

out of 10

Value Trap

48

WARN

Price

$2.83

Last close

Models

10/13

Active

VS

SRRK

Biotechnology

Scholar Rock Holding Corporatio

Quality

5.1

out of 10

Value Trap

30

LOW

Price

$44.68

Last close

Models

10/13

Active

SPRO

2 models active

Value Trap 48/100 — caution

SRRK

2 models active

Limited to 2/13 visible models

SPRO vs SRRK — Fair Value Comparison

SPRO

SRRK

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	SPRO Fair Value	SPRO Upside	SRRK Fair Value	SRRK Upside
Bayesian DCF	Intrinsic	$1.25	-55.9%	$14.50	-67.6%
Earnings Power Value	Intrinsic	—	—	$21.36	-54.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.96	-30.6%	$4.25	-90.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

SPRO vs SRRK — Which Stock Is More Undervalued in 2026?

SPRO scores higher with a 7.5/10 quality rating vs SRRK's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do SPRO and SRRK Valuations Compare?

At $2.83, SPRO trades +55.9% above its Bayesian DCF fair value of $1.25, while SRRK at $44.68 trades +67.6% above its estimate of $14.50. SRRK shows a wider gap between price and intrinsic value.

Quality of Company: SPRO vs SRRK

SPRO earns a Quality of Company score of 7.5/10 compared to SRRK's 5.1/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: SPRO vs SRRK

SPRO carries a WARN value trap risk (48/100) while SRRK shows LOW risk (30/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.

Both in Biotechnology

Both SPRO and SRRK operate in Biotechnology, which has 566 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare SPRO vs SRRK differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

SPRO

View Full Spero Therapeutics, Inc. Analysis →

SRRK

View Full Scholar Rock Holding Corporatio Analysis →

See all Biotechnology stocks →